B 100 Complex Timed Release
Natural health product licensed in Canada
- Licence holder
- Nutricorp International
- NPN or DIN-HM
- 02239971
- Status
- Active licence
- Licence date
- 15 October 2007
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Niacine | 100 mg | Not calculated |
| Acide para-aminobenzoïque | 7 mg | Not calculated |
Non-medicinal ingredients
cellulose, Acide stéarique, Cire de Carnauba, Dioxyde de silicium, Stéarate de magnésium, Hypromellose, Poly(éthylène glycol), Menthe poivrée, Phosphate de dicalcium dihydrate, Dicalcium Phosphate Anhydrous
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | Not specified |
Uses authorised in Canada
For the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking levodopa or igf you have impaired liver function.
Source
Official Health Canada record, licence 02239971
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.